Regeneron Pharmaceuticals Inc (REGN) — the peer cohort
As of 2026-11-10 — scores re-bake nightly. Cohort = shared Closelooknet index membership first, then sector. Diary readings, not advice.
Regeneron Pharmaceuticals Inc ranks 5 of 16 in its cohort on the Closelooknet composite (64/100) — the cohort is led by Halozyme Therapeutics Inc at 70/100.
| Name | Composite | Momentum | Quality | Valuation | Signal | Off 52w high |
|---|---|---|---|---|---|---|
| REGN Regeneron Pharmaceuticals Inc | 64 | 84 | 72 | 45 | bull | 7.2% |
| RACE Ferrari NV | 66 | 79 | 83 | 23 | watch | 15.5% |
| LLY Eli Lilly and Company | 64 | 91 | 90 | 22 | bull | 2.8% |
| DXCM DexCom Inc | 62 | 67 | 79 | 34 | watch | 12.4% |
| HDB HDFC Bank Limited ADR | 62 | 52 | 66 | 80 | bull | 28.9% |
| TOST Toast Inc | 62 | 76 | 51 | 41 | watch | 12.5% |
| GMED Globus Medical | 60 | 37 | 65 | 53 | bull | 24.7% |
| ONON On Holding Ltd | 60 | 45 | 69 | 45 | watch | 26.5% |
| VRSK Verisk Analytics Inc | 60 | 69 | 88 | 33 | neutral | 19.2% |
| FAST Fastenal Company | 59 | 83 | 71 | 19 | bull | 0.8% |
| IDXX IDEXX Laboratories Inc | 59 | 71 | 85 | 17 | bull | 8.2% |
| ZEAL.CO Zealand Pharma A/S | 59 | 11 | 71 | 77 | bull | 55.9% |
| HALO Halozyme Therapeutics Inc | 70 | 76 | 94 | 36 | info | 23.1% |
| ARGX.BR Argen-X | 65 | 85 | 75 | 28 | ok | 6.6% |
| ONC BeOne Medicines AG | 65 | 91 | 64 | 29 | ok | 0.2% |
| UCB.BR UCB SA | 64 | 77 | 71 | 41 | info | 2.2% |
Scores are relative readings across the Closelooknet coverage universe — methodology in the company-scoring explainer. Signal lights come from the nightly signal board.
FAQ · from the current data · as of 2026-11-10
Quick answers
Who are Regeneron Pharmaceuticals Inc's peers in the Closelooknet universe?
The cohort is drawn from shared Closelooknet index membership first, then sector: Ferrari NV (RACE), Eli Lilly and Company (LLY), DexCom Inc (DXCM), HDFC Bank Limited ADR (HDB), Toast Inc (TOST), Globus Medical (GMED), On Holding Ltd (ONON), Verisk Analytics Inc (VRSK) and others, as of 2026-11-10.
How does REGN score against its peers?
Regeneron Pharmaceuticals Inc's composite reads 64/100, ranking 5 of 16 in its cohort as of 2026-11-10; the cohort's highest composite is Halozyme Therapeutics Inc at 70/100. Closelooknet scores are research diary readings, not ratings or advice.
Mentioned on Closelooknet
Where REGN appears in the diary — 1 piece, newest first. Every link is our own writing.
Go deeper
Dailies
- A chart pick published at 95.10 this morning trades 107.92 by midday — Robinhood's triangle breaks up through the 100 shelf — as the CAC snaps seven straight red sessions and Bitcoin adds another six percent above 77,000
Barchart's large-cap 52-week new-high list, as of 11:59 CDT, carries 31 names and reads like the ex-tech thesis printed as breadth: twelve are health care, biotech or pharma — ARGX, BDX, BIO, CORT, HALO, MRK, REGN, RVTY, THC, TVTX, TXG…
Related in the Closelooknet universe
same Closelooknet index seat first, then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- RACE Ferrari NV
- LLY Eli Lilly and Company
- DXCM DexCom Inc
- HDB HDFC Bank Limited ADR
- TOST Toast Inc
- GMED Globus Medical
- ONON On Holding Ltd
- VRSK Verisk Analytics Inc
- FAST Fastenal Company
- IDXX IDEXX Laboratories Inc
- ZEAL.CO Zealand Pharma A/S
- ERJ Embraer S.A.
- HALO Halozyme Therapeutics Incindustry
- ARGX.BR Argen-Xindustry
- ONC BeOne Medicines AGindustry
- UCB.BR UCB SAindustry
- ARGX argenx NV ADRindustry
- RIGL Rigel Pharmaceuticals Incindustry
- REPL Replimune Group Incindustry
- KOD Kodiak Sciences Incindustry